第一作者:
Beiping,Miao
第一单位:
German Cancer Research Center (DKFZ) Heidelberg, Division Immune Regulation in Cancer, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany; State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
作者:
Beiping,Miao [1]
;
Zhaoqing,Hu [2]
;
Riccardo,Mezzadra [3]
;
Lotte,Hoeijmakers [4]
;
Astrid,Fauster [5]
;
Shangce,Du [6]
;
Zhi,Yang [7]
;
Melanie,Sator-Schmitt [8]
;
Helena,Engel [2]
;
Xueshen,Li [9]
;
Caroline,Broderick [10]
;
Guangzhi,Jin [11]
;
Raquel,Gomez-Eerland [4]
;
Lisette,Rozeman [4]
;
Xin,Lei [12]
;
Hitoshi,Matsuo [2]
;
Chen,Yang [1]
;
Ingrid,Hofland [13]
;
Dennis,Peters [13]
;
Annegien,Broeks [13]
;
Elke,Laport [8]
;
Annika,Fitz [8]
;
Xiyue,Zhao [2]
;
Mohamed A A,Mahmoud [2]
;
Xiujian,Ma [14]
;
Sandrine,Sander [15]
;
Hai-Kun,Liu [16]
;
Guoliang,Cui [17]
;
Yu,Gan [9]
;
Wei,Wu [18]
;
Yanling,Xiao [12]
;
Albert J R,Heck [19]
;
Wenxian,Guan [7]
;
Scott W,Lowe [10]
;
Hugo M,Horlings [20]
;
Cun,Wang [21]
;
Thijn R,Brummelkamp [5]
;
Christian U,Blank [22]
;
Ton N M,Schumacher [23]
;
Chong,Sun [24]
作者单位:
German Cancer Research Center (DKFZ) Heidelberg, Division Immune Regulation in Cancer, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany; State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
[1]
German Cancer Research Center (DKFZ) Heidelberg, Division Immune Regulation in Cancer, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany; Faculty of Biosciences, Heidelberg University, 69120 Heidelberg, Germany.
[2]
Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Oncode Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands; Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
[3]
Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Oncode Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands.
[4]
Division of Biochemistry, Netherlands Cancer Institute, Oncode Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands.
[5]
German Cancer Research Center (DKFZ) Heidelberg, Division Immune Regulation in Cancer, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany; Faculty of Medicine, Heidelberg University, 69120 Heidelberg, Germany.
[6]
Department of Gastrointestinal Surgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China.
[7]
German Cancer Research Center (DKFZ) Heidelberg, Division Immune Regulation in Cancer, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.
[8]
Department of Biomedical Engineering, Stevens Institute of Technology, Hoboken, NJ 07030, USA.
[9]
Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
[10]
Department of Interventional Radiology, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, No. 1111, Xianxia Road, Shanghai 200336, China.
[11]
Department of Immunology, Leiden University Medical Center (LUMC), Leiden, the Netherlands.
[12]
Core Facility Molecular Pathology & Biobanking, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands.
[13]
Faculty of Medicine, Heidelberg University, 69120 Heidelberg, Germany; German Cancer Research Center (DKFZ) Heidelberg, Division Molecular Neurogenetics, DKFZ-ZMBH Alliance, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.
[14]
German Cancer Research Center (DKFZ) Heidelberg, Division Adaptive Immunity and Lymphoma , Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.
[15]
German Cancer Research Center (DKFZ) Heidelberg, Division Molecular Neurogenetics, DKFZ-ZMBH Alliance, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.
[16]
German Cancer Research Center (DKFZ) Heidelberg, Division T Cell Metabolism, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.
[17]
Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, Padualaan 8, 3584 CH Utrecht, the Netherlands; Netherlands Proteomics Centre, Padualaan 8, 3584 CH Utrecht, the Netherlands; Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A(∗)STAR), Singapore 138648, Singapore; Department of Pharmacy, National University of Singapore, Singapore 117543, Singapore.
[18]
Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, Padualaan 8, 3584 CH Utrecht, the Netherlands; Netherlands Proteomics Centre, Padualaan 8, 3584 CH Utrecht, the Netherlands.
[19]
Department of Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands.
[20]
State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
[21]
Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Oncode Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands; Department of Medical Oncology, Netherlands Cancer Institute (NKI), Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands; Department of Medical Oncology, Leiden University Medical Centre (LUMC), Leiden, The Netherlands. Electronic address: c.blank@nki.nl.
[22]
Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Oncode Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands; Department of Hematology, Leiden University Medical Center (LUMC), Leiden, the Netherlands. Electronic address: t.schumacher@nki.nl.
[23]
German Cancer Research Center (DKFZ) Heidelberg, Division Immune Regulation in Cancer, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany. Electronic address: c.sun@dkfz.de.
[24]
医学主题词
人类(Humans);免疫(Immunity);免疫疗法(Immunotherapy);肿瘤(Neoplasms);T淋巴细胞(T-Lymphocytes);髓磷脂蛋白质类(Myelin Proteins)
DOI
10.1016/j.ccell.2023.08.008
PMID
37683639
发布时间
2024-09-13
- 浏览1
Cancer cell
Cancer cell
1817-1828.e9页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文





换一批



